320 related articles for article (PubMed ID: 7756099)
1. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
[TBL] [Abstract][Full Text] [Related]
2. Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
Int J Cardiol; 1991 Dec; 33(3):377-83. PubMed ID: 1761331
[TBL] [Abstract][Full Text] [Related]
3. Captopril augments both basal and frusemide-induced natriuresis in normal man by suppression of circulating angiotensin II.
Motwani JG; Struthers AD
Br J Clin Pharmacol; 1992 Jul; 34(1):25-31. PubMed ID: 1633064
[TBL] [Abstract][Full Text] [Related]
4. Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
Eur Heart J; 1991 Aug; 12(8):924-7. PubMed ID: 1915430
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting potassium balance during frusemide administration.
Wilcox CS; Mitch WE; Kelly RA; Friedman PA; Souney PF; Rayment CM; Meyer TW; Skorecki KL
Clin Sci (Lond); 1984 Aug; 67(2):195-203. PubMed ID: 6378491
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
7. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
Motwani JG; Fenwick MK; Morton JJ; Struthers AD
Circulation; 1992 Aug; 86(2):439-45. PubMed ID: 1638713
[TBL] [Abstract][Full Text] [Related]
8. Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
Motwani JG; Fenwick MK; Morton JJ; Struthers AD
Am J Cardiol; 1994 Jun; 73(16):1191-6. PubMed ID: 8203337
[TBL] [Abstract][Full Text] [Related]
9. Captopril does not prevent nitroglycerin tolerance in heart failure.
Dupuis J; Lalonde G; Bichet D; Rouleau JL
Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
[TBL] [Abstract][Full Text] [Related]
10. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
Good JM; Brady AJ; Noormohamed FH; Oakley CM; Cleland JG
Circulation; 1994 Jul; 90(1):220-4. PubMed ID: 8026000
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
[TBL] [Abstract][Full Text] [Related]
12. Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure.
Fett DL; Cavero PG; Burnett JC
J Am Soc Nephrol; 1993 Aug; 4(2):162-7. PubMed ID: 8400079
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
Sica D; Oren RM; Gottwald MD; Mills RM;
Clin Cardiol; 2010 Jun; 33(6):330-6. PubMed ID: 20556802
[TBL] [Abstract][Full Text] [Related]
14. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
15. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
Lee AF; MacFadyen RJ; Struthers AD
Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
[TBL] [Abstract][Full Text] [Related]
16. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
Jiang M
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
[TBL] [Abstract][Full Text] [Related]
17. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
18. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
19. Effects of interrupting the renin-angiotensin system on sodium excretion in man.
Brown J
J Physiol; 1988 Jan; 395():17-40. PubMed ID: 3045295
[TBL] [Abstract][Full Text] [Related]
20. Modulation of natriuresis and renal dopamine excretion by sympathetic activity and the renin-angiotensin-aldosterone system.
Barendregt JN; van Nispen tot Pannerden LA; Chang PC
J Hum Hypertens; 1994 Oct; 8(10):747-54. PubMed ID: 7837211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
